IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i15p7913-d601734.html
   My bibliography  Save this article

Factors Influencing Care Pathways for Breast and Prostate Cancer in a Hospital Setting

Author

Listed:
  • Ornela Bardhi

    (eVida Laboratory, University of Deusto, Avenida Universidades 24, 48007 Bilbao, Spain
    UCD Beacon Hospital Academy, Beacon Hospital, Sandyford, D18 AK68 Dublin, Ireland)

  • Begonya Garcia-Zapirain

    (eVida Laboratory, University of Deusto, Avenida Universidades 24, 48007 Bilbao, Spain)

  • Roberto Nuño-Solinis

    (Deusto Business School Health, University of Deusto, Avenida Universidades 24, 48007 Bilbao, Spain)

Abstract

Breast cancer (BCa) and prostate cancer (PCa) are the most prevalent types of cancers. We aimed to understand and analyze the care pathways for BCa and PCa patients followed at a hospital setting by analyzing their different treatment lines. We evaluated the association between different treatment lines and the lifestyle and demographic characteristics of these patients. Two datasets were created using the electronic health records (EHRs) and information collected through semi-structured one-on-one interviews. Statistical analysis was performed to examine which variable had an impact on the treatment each patient followed. In total, 83 patients participated in the study that ran between January and November 2018 in Beacon Hospital. Results show that chemotherapy cycles indicate if a patient would have other treatments, i.e., patients who have targeted therapy (25/46) have more chemotherapy cycles (95% CI 4.66–9.52, p = 0.012), the same is observed with endocrine therapy (95% CI 4.77–13.59, p = 0.044). Patients who had bisphosphonate (11/46), an indication of bone metastasis, had more chemotherapy cycles (95% CI 5.19–6.60, p = 0.012). PCa patients with tall height (95% CI 176.70–183.85, p = 0.005), heavier (95% CI 85.80–99.57, p < 0.001), and a BMI above 25 (95% CI 1.85–2.62, p = 0.017) had chemotherapy compared to patients who were shorter, lighter and with BMI less than 25. Initial prostate-specific antigen level (PSA level) indicated if a patient would be treated with bisphosphonate or not (95% CI 45.51–96.14, p = 0.002). Lifestyle variables such as diet (95% CI 1.46–1.85, p = 0.016), and exercise (95% CI 1.20–1.96, p = 0.029) indicated that healthier and active BCa patients had undergone surgeries. Our findings show that chemotherapy cycles and lifestyle for BCa, and tallness and weight for PCa may indicate the rest of treatment plan for these patients. Understanding factors that influence care pathways allow a more person-centered care approach and the redesign of care processes.

Suggested Citation

  • Ornela Bardhi & Begonya Garcia-Zapirain & Roberto Nuño-Solinis, 2021. "Factors Influencing Care Pathways for Breast and Prostate Cancer in a Hospital Setting," IJERPH, MDPI, vol. 18(15), pages 1-16, July.
  • Handle: RePEc:gam:jijerp:v:18:y:2021:i:15:p:7913-:d:601734
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/15/7913/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/18/15/7913/
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mario Rivera-Izquierdo & Virginia Martínez-Ruiz & José Juan Jiménez-Moleón, 2022. "Recommendations on Weight Loss and Healthy Lifestyle in Prostate Cancer Clinical Guidelines: A Systematic Review," IJERPH, MDPI, vol. 19(3), pages 1-17, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:15:p:7913-:d:601734. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.